Anesthesia Protocols for MDR1-Affected Dogs: A Veterinary Guide

Every year, thousands of MDR1-affected dogs undergo routine surgical procedures, from spays and neuters to dental cleanings and tumor removals. Most of these procedures go smoothly. But when they go wrong in an MDR1 dog, they go wrong in ways that are both predictable and preventable. I have consulted on cases where M/M dogs were sedated with standard-dose acepromazine before surgery and remained profoundly sedated for 18 hours afterward. I have reviewed records where butorphanol was given at normal doses and caused respiratory depression that required intubation before anesthesia even began.

The central problem is not that MDR1 dogs cannot undergo anesthesia. They absolutely can. The problem is that the standard protocols taught in veterinary schools and used in most general practices were designed for dogs with functional P-glycoprotein. When the blood-brain barrier leaks, drug pharmacokinetics change in ways that demand adjusted protocols at every stage: pre-medication, induction, maintenance, and recovery.

Why Anesthesia Is Different in MDR1 Dogs

P-glycoprotein is expressed at the blood-brain barrier, where it actively pumps lipophilic compounds back into the bloodstream. Many anesthetic and analgesic agents are P-gp substrates or are affected by P-gp function. In M/M dogs with no functional P-gp, these drugs reach higher brain concentrations, produce stronger effects, and take longer to clear from the central nervous system.

The practical consequence is straightforward: standard doses produce exaggerated responses, onset may be faster, and recovery takes longer. This applies unevenly across drug classes. Some anesthetic agents are minimally affected by P-gp status, while others are dramatically altered. Knowing which drugs fall into which category is the foundation of safe MDR1 anesthesia.

Pre-Anesthetic Sedation

Pre-medication serves two purposes: reducing patient anxiety and decreasing the amount of induction agent required. In MDR1 dogs, the choice of pre-anesthetic agent matters more than in normal patients.

Acepromazine: Use With Extreme Caution

Acepromazine is one of the most commonly used pre-anesthetic sedatives in veterinary practice. It is also a documented P-gp substrate with significantly enhanced effects in MDR1 dogs.

My recommendation: avoid acepromazine entirely in M/M dogs when possible. If it must be used, reduce the dose to one-quarter of normal and wait a full 45 minutes before assessing effect. Do not redose if the initial sedation appears insufficient before this time period. The delayed peak effect in MDR1 dogs means premature redosing can produce dangerous cumulative sedation.

Dexmedetomidine: The Preferred Alternative

Dexmedetomidine (Dexdomitor) is my preferred pre-anesthetic sedative for MDR1 dogs for one critical reason: it has a specific reversal agent. Atipamezole (Antisedan) can fully reverse dexmedetomidine effects within minutes if sedation becomes excessive or complications arise.

Dexmedetomidine is not a significant P-gp substrate, but I still recommend starting at the lower end of the dosing range (2-5 mcg/kg IM) in MDR1 dogs because their overall drug sensitivity may be heightened. The reversibility provides a safety margin that acepromazine simply cannot match.

Trazodone and Gabapentin for Pre-Procedure Anxiety

For the anxious MDR1 dog that needs oral sedation before even arriving at the clinic, trazodone (2-5 mg/kg PO, given 1-2 hours prior) and gabapentin (5-10 mg/kg PO, given 2 hours prior) are safe choices. Neither is a significant P-gp substrate. They reduce anxiety without the risks associated with phenothiazines in MDR1 patients.

Induction Agents

Anesthetic induction is the transition from sedation to full general anesthesia. The choice of induction agent is less affected by MDR1 status than pre-medication, but adjustments still matter.

Propofol

Propofol is not a significant P-gp substrate and remains the induction agent of choice for MDR1 dogs. Standard titration-to-effect dosing (2-6 mg/kg IV, given slowly to effect) works well. The key principle is to titrate slowly. Because MDR1 dogs may have enhanced CNS sensitivity to other agents given during pre-medication, they often require less propofol for induction than expected.

Alfaxalone

Alfaxalone (Alfaxan) is an excellent alternative to propofol. It is a neurosteroid anesthetic with minimal P-gp interaction. Standard dosing (1-3 mg/kg IV, titrated to effect) is appropriate. Alfaxalone provides smooth induction with predictable recovery and is particularly useful in MDR1 dogs because of its wide safety margin.

Ketamine Combinations

Ketamine is not a P-gp substrate and can be used safely in MDR1 dogs. Ketamine-diazepam or ketamine-midazolam combinations at standard doses are acceptable. However, recovery from ketamine can be rough if post-operative sedation protocols are not carefully managed.

Intraoperative Maintenance

Isoflurane and sevoflurane are the standard inhalant anesthetic agents, and neither is meaningfully affected by P-gp status. MDR1 dogs can be maintained on inhalant anesthesia at standard concentrations. However, MAC (minimum alveolar concentration) requirements may be slightly reduced due to residual effects of pre-anesthetic agents that persist longer in MDR1 patients.

Monitor anesthetic depth closely and be prepared to reduce vaporizer settings sooner than you would in a normal patient. Clinical signs of excessive anesthetic depth (absent palpebral reflex, jaw tone loss, cardiovascular depression) should prompt immediate vaporizer reduction.

Intraoperative Analgesia

Pain management during surgery requires particular attention in MDR1 dogs:

Local and regional anesthesia techniques deserve special emphasis for MDR1 patients. Nerve blocks, epidural analgesia, and local infiltration are not affected by P-gp status and provide excellent analgesia without systemic drug exposure. Whenever possible, incorporate regional techniques to reduce reliance on opioid analgesics.

Recovery and Post-Operative Care

Recovery is where MDR1 dogs diverge most dramatically from normal patients. Expect extended recovery times with any protocol that includes P-gp substrate drugs. A normal dog recovering from propofol induction and isoflurane maintenance might be standing within 15-30 minutes. An M/M dog given acepromazine pre-medication may remain deeply sedated for hours after the inhalant is discontinued.

Recovery Monitoring Protocol

• Temperature: Monitor closely. MDR1 dogs are more prone to hypothermia during prolonged recovery. Use warming blankets and warm IV fluids.
• Respiratory rate: Count respirations every 15 minutes during recovery. Opioid-enhanced respiratory depression may emerge as inhalant effects wane.
• Heart rate and rhythm: Bradycardia may persist longer than expected if opioids or dexmedetomidine were used.
• Neurological status: Assess pupil response, jaw tone, and response to stimuli at regular intervals. Prolonged CNS depression warrants extended monitoring.
• Pain assessment: Use validated pain scoring tools. MDR1 dogs may need less frequent opioid dosing post-operatively due to prolonged drug effects.

Post-Operative Analgesia

For post-operative pain management, favor non-P-gp-substrate analgesics. Note that some of the drugs listed here overlap with compounds found in flea and tick preventatives, so always verify that your dog's full medication regimen is MDR1-compatible:

• NSAIDs: Carprofen (2.2 mg/kg PO BID) or meloxicam (0.1 mg/kg PO once daily) are first-line choices
• Gabapentin: 5-10 mg/kg PO BID-TID for neuropathic or adjunctive pain control
• Tramadol: 2-5 mg/kg PO BID-TID has minimal P-gp interaction
• Cold therapy and rest: Non-pharmacological approaches reduce drug requirements

If opioids are necessary for post-operative pain, use reduced doses and extend dosing intervals. A butorphanol dose that lasts 2-4 hours in a normal dog may provide adequate analgesia for 6-8 hours in an M/M patient.

Emergency Preparedness During Anesthesia

Every anesthetic event in an MDR1 dog should include specific emergency preparations:

• Reversal agents on hand: Atipamezole for dexmedetomidine, naloxone for opioids, flumazenil for benzodiazepines
• Intubation equipment ready: Even for procedures that would not normally require intubation, have endotracheal tubes available
• IV catheter placed before pre-medication: Ensures immediate venous access for emergencies
• Extended monitoring plan: Staff the recovery area for longer than usual; do not discharge until the patient is fully ambulatory and normothermic

Communicating With Your Veterinarian

If your MDR1 dog needs surgery, bring the following information to the pre-surgical consultation:

1. Written documentation of MDR1 genotype (M/M or N/M)
2. A copy of the drug avoidance list from our complete drug reference
3. Any history of previous anesthetic events and how your dog responded
4. Request that the anesthetic protocol be documented in writing before the procedure

Most veterinarians are receptive to this discussion when it is framed as collaboration rather than criticism. You are providing information that helps them keep your dog safe. The Ivermectin Sensitivity guide on MDR1 mutations offers an accessible summary you can share with veterinary staff who may be less familiar with the pharmacogenetics involved.

Special Considerations for Common Procedures

Spay/Neuter

Routine sterilization surgery is safe in MDR1 dogs with adjusted protocols. I recommend: dexmedetomidine pre-medication, propofol induction, isoflurane maintenance, and multimodal analgesia emphasizing NSAIDs and local techniques. A splash block with bupivacaine at the incision site reduces opioid requirements significantly.

Dental Procedures

Dental cleanings and extractions require particular attention because the procedure duration can vary significantly. Use the same adjusted anesthetic protocol, and ensure adequate local nerve blocks for extractions. Infraorbital and inferior alveolar nerve blocks with bupivacaine provide excellent dental analgesia without systemic effects.

Emergency Surgery

Emergency situations do not allow the luxury of perfect protocol planning. If an MDR1 dog requires emergency surgery and its genotype is known, default to the safest available protocols: propofol or alfaxalone induction, inhalant maintenance, regional anesthesia when feasible, and reduced-dose opioids with close monitoring. If MDR1 status is unknown and the dog is a herding breed, assume M/M and proceed accordingly. Refer to our emergency protocol guide for additional guidance on acute situations.

A Final Note on Communication

The most important factor in safe anesthesia for MDR1 dogs is not any single drug choice. It is communication. The surgeon needs to know. The anesthetist needs to know. The recovery nurse needs to know. The after-hours team covering overnight recovery needs to know. MDR1 status should be flagged in the medical record so prominently that it is impossible to miss.

I have seen perfectly good anesthetic protocols fall apart because the overnight technician administered standard-dose butorphanol for post-operative pain, unaware that the patient was M/M. Preventing that failure is a systems problem, not a pharmacology problem. Make your dog's MDR1 status impossible to overlook. While we continue refining these protocols, gene therapy research offers hope that future treatments may restore P-glycoprotein function and eliminate the need for such extensive anesthetic adjustments.